India’s Covid-19 fatality rate drops to 1.46%; Govt targets bringing it down to 1%

Of the 10 worst-affected Covid-19 states and union territories, Delhi is reporting the maximum number of new deaths
India’s coronavirus disease (Covid-19) case fatality rate (CFR) dropped to 1.46% on Sunday, with 133,771 of 9,140,191 infected persons having succumbed to the viral infection in the country.
The first death due to Covid-19 was reported in India on March 12, 2020.With the Covid-19 CFR steadily declining, the country is inching closer to the target that the Indian government has set—attaining a CFR of 1% or below.
The government target has been set keeping in mind the number of deaths that occur annually due to common influenza in the country.
According to government officials in the know of things, the target percentage was decided after a detailed deliberation between representatives of the union ministry of health and family welfare and the government think tank Niti Aayog.
Ten states have been reporting the maximum number of deaths from across the country, with about 77% of the 509 case fatalities that have been reported on Sunday recorded by these 10 states and union territories.
Of the 10 worst-affected Covid-19 states and union territories, Delhi is reporting the maximum number of new deaths. On Sunday, 121 deaths due to Covid-19 were reported from Delhi, taking the total number of people having died of the viral infection to 8,391, which comprises roughly over 22% of the total new deaths reported from across the country on the day.
The other affected states in the terms of higher Covid-19 deaths are Maharashtra, West Bengal, and Uttar Pradesh.
The government has been majorly focusing on vaccine development, procurement and delivery, as an effective vaccine is going to be the key to bring down the rate of infection in the long run.
Apart from taking several other steps to curb the disease transmission, the government has also provided assistance of Rs900 crore under Covid Suraksha Mission to support research and development of Covid-19 vaccination.
ABOUT THE AUTHORRhythma KaulRhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More
Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.

E-Paper


